SNIPER-LTFU: Long-term follow-up study of patients administered with RR001 in the interventional Parent SNIPER study
Key facts
- Where
- Modena, OlaszországSee the site
- Phase
- 1/2. fázis
Where in Olaszország
- Azienda Ospedaliero - Universitaria di ModenaModena, OlaszországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Eir Biotherapies S.r.l.
- Trial code
- EU 2026-525714-59-00
- Record updated
- 2026. október 9.
- Original description
To assess the long term safety profile (93 months LTFU period) of patients who completed SNIPER study.Read full original descriptionShow less
To assess the long term safety profile (93 months LTFU period) of patients who completed SNIPER study.
Inclusion: Patients who participated in SNIPER study and have been treated by RR001; Patients who completed the SNIPER End of Study visit, regardless of treatment outcome; Patients who signed informed consent for long-term follow-up and data collection in accordance with GDPR and who are able to comply with study requirements; For all patients with childbearing age or not surgically sterile, agreement to use highly effective and adequate method of contraception for at least 12 months following RR001 administration (including both females of childbearing potential and males with partners of childbearing potential).
Exclusion: Inability to be contacted for follow-up and to come to the site for SOC (Standard of Care) activities; Female patients with pregnancy or breast feeding.